Author

Elisabeth N. Kapaki

Observed names: E. Kapaki, ELISABETH KAPAKI, Elisabeth Kapaki

Institutions: National and Kapodistrian University of Athens, Eginition Hospital

Observed institutions: Alzheimer's Association, San Francisco VA Medical Center, The University of Melbourne, University of California, San Francisco, National and Kapodistrian University of Athens, Florey Institute of Neuroscience and Mental Health, Sahlgrenska University Hospital, University General Hospital Attikon, Eginition Hospital, University of Gothenburg

OpenAlex ID: A5104089696

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

2015 · Willemijn J. Jansen, Rik Ossenkoppele, et al. · JAMA · 1,608

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

2011 · Niklas Mattsson, Ulf Andreasson, et al. · Alzheimer s & Dementia · 413

PDF

CSF biomarker variability in the Alzheimer's Association quality control program

2013 · Niklas Mattsson, Ulf Andreasson, et al. · Alzheimer s & Dementia · 382

PDF

Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update

2012 · Marta del Campo, Brit Mollenhauer, et al. · Biomarkers in Medicine · 344

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

2022 · Willemijn J. Jansen, Olin Janssen, et al. · JAMA Neurology · 290

PDF

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

2017 · Willemijn J. Jansen, Rik Ossenkoppele, et al. · JAMA Psychiatry · 140

PDF

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease

2018 · Anders Wallin, Gustavo C. Román, et al. · Journal of Alzheimer s Disease · 126

PDF

Neurofilament ELISA validation

2009 · Axel Petzold, Ayse Altintas, et al. · Journal of Immunological Methods · 105

PDF

Corticobasal degeneration and corticobasal syndrome: A review

2019 · Vasilios C. Constantinides, George P. Paraskevas, et al. · Clinical Parkinsonism & Related Disorders · 100

PDF

The Utility of α-Synuclein as Biofluid Marker in Neurodegenerative Diseases: a Systematic Review of The Literature

2015 · Anja Hviid Simonsen, Bea Kuiperij, et al. · Biomarkers in Medicine · 94

Novel mutations and repeated findings of mutations in familial Alzheimer disease

2005 · Ulrich Finckh, Christian Kuschel, et al. · Neurogenetics · 85

Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis

2019 · Anastasia Bougea, Leonidas Stefanis, et al. · Neurological Sciences · 83

CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes

2017 · Vasilios C. Constantinides, George P. Paraskevas, et al. · Journal of the Neurological Sciences · 80

Increased Cerebrospinal Fluid Tau Protein in Multiple Sclerosis

2000 · Elisabeth Kapaki, George P. Paraskevas, et al. · European Neurology · 80

The Diagnostic Value of CSF α-Synuclein in the Differential Diagnosis of Dementia with Lewy Bodies vs. Normal Subjects and Patients with Alzheimer’s Disease

2013 · Elisabeth Kapaki, George P. Paraskevas, et al. · PLoS ONE · 79

PDF

Motor and Nonmotor Features of Carriers of the p.A53T Alpha‐Synuclein Mutation: A Longitudinal Study

2016 · Dimitra Papadimitriou, Roubina Antonelou, et al. · Movement Disorders · 78

Comorbidity of Cognitive Impairment and Late-Life Depression Increase Mortality

2016 · Marios K. Georgakis, Fotios C. Papadopoulos, et al. · Journal of Geriatric Psychiatry and Neurology · 78

Cholesterol 25-Hydroxylase on Chromosome 10q Is a Susceptibility Gene for Sporadic Alzheimer’s Disease

2005 · Andreas Papassotiropoulos, Jean-Charles Lambert, et al. · Neurodegenerative Diseases · 64

PDF

Essential trace element alterations in amyotrophic lateral sclerosis

1997 · Elisabeth Kapaki, Christos Zournas, et al. · Journal of the Neurological Sciences · 64

Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia

2006 · Michael Rentzos, George P. Paraskevas, et al. · Journal of the Neurological Sciences · 62

Diagnostic Value of CSF Biomarker Profile in Frontotemporal Lobar Degeneration

2008 · Elisabeth Kapaki, George P. Paraskevas, et al. · Alzheimer Disease & Associated Disorders · 59

Association study of cholesterol-related genes in Alzheimer’s disease

2007 · M. Axel Wollmer, Kristel Sleegers, et al. · Neurogenetics · 58

PDF

Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders

2017 · Mara Bourbouli, Michael Rentzos, et al. · Dementia and Geriatric Cognitive Disorders · 55

Ethnicity‐dependent genetic association of ABCA2 with sporadic Alzheimer's disease

2006 · M. Axel Wollmer, Elisabeth Kapaki, et al. · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · 55

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease

2019 · Stylianos Ravanidis, Anastasia Bougea, et al. · Movement Disorders · 54

Works count: 150

Citation count: 6,153

H-index: 34

I10-index: 85